PetMedix Ltd

PetMedix is a research and development stage biopharmaceutical company developing antibody-based therapeutics for companion animals. Driven by the core value of improving the health and welfare of animals, PetMedix is taking the cutting edge of human medicine and using it to develop innovative new veterinary treatments against a wide range of clinical indications for dogs and cats.

Address :
The Glenn Berge Building Babraham Research Campus Cambridge
Post Code: CB22 3FH
Country: United Kingdom
Membership Type: Corporate 21-50